TRVI
USDTrevi Therapeutics Inc. Common Stock
$10.860+0.410 (3.923%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$10.450
High
$10.980
Low
$10.450
Volume
2.49M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.13M
Exchange
NGM
Currency
USD
52-Week Range
Low $2.36Current $10.860High $11.83
Related News
PR Newswire
Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference
Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine...
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.